MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
128 hedge funds and large institutions have $574M invested in Merrimack Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 47 increasing their positions, 31 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
44% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 27
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
128
Holding in Top 10
–
Calls
$1.52M
Puts
$2.15M
Top Buyers
| 1 | +$37.8M | |
| 2 | +$15.5M | |
| 3 | +$5.98M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$4.34M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.75M |
Top Sellers
| 1 | -$7.55M | |
| 2 | -$4.01M | |
| 3 | -$2.37M | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$2.27M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$1.68M |